Stocks › QDEL
QuidelOrtho Corp
QDEL·Nasdaq·
United States·USD
$8.32
-0.60 (-6.73%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
QDEL
QuidelOrtho Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
QDELS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of QDEL by members of U.S. Congress · 18 on record
Whale Activity
Position changes in QDEL reported for 2026-09-30 by 284 institutional filers
- Increased78
- New41
- Held35
- Decreased74
- Closed42
- No prior filing14
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 11.1M | $117.4M | decreased |
| Newtyn Management, LLC | 5.3M | $56.3M | decreased |
| FMR LLC | 4.0M | $41.6M | decreased |
| AMERICAN CENTURY COMPANIES INC | 3.9M | $41.4M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | $38.3M | decreased |
| Invesco Ltd. | 3.6M | $38.0M | increased |
| Rubric Capital Management LP | 3.1M | $33.0M | decreased |
| STATE STREET CORP | 3.0M | $31.9M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $31.8M | decreased |
| Neuberger Berman Group LLC | 2.9M | $31.1M | decreased |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 2.4M | $25.2M | decreased |
| PRIVATE MANAGEMENT GROUP INC | 2.3M | $24.1M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by QDEL insiders, by quarter · Form 4
Recent Insider Transactions
2,168 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Bowman Ronald LeeChief Human Resources Officer | Tax withholding | −921 | $10.63 | $10K | Sep 15, 2026 | Form 4 ↗ |
| Bowman Ronald LeeChief Human Resources Officer | Option exercise | +2,566 | $0.00 | $0 | Sep 15, 2026 | Form 4 ↗ |
| Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Tax withholding | −162 | $14.30 | $2K | Aug 15, 2026 | Form 4 ↗ |
| Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Option exercise | +446 | $0.00 | $0 | Aug 15, 2026 | Form 4 ↗ |
| Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Tax withholding | −2,096 | $18.18 | $38K | Jul 1, 2026 | Form 4 ↗ |
| Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Option exercise | +5,797 | $0.00 | $0 | Jul 1, 2026 | Form 4 ↗ |
| Michael Edward L.Director | Grant / award | +289 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| Michael Edward L.Director | Grant / award | +963 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| BUECHLER KENNETH FDirector | Grant / award | +497 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| BUECHLER KENNETH FDirector | Grant / award | +1,659 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| POLAN MARY LAKE PH DDirector | Grant / award | +224 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| POLAN MARY LAKE PH DDirector | Grant / award | +749 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| WIDDER KENNETH JDirector | Grant / award | +273 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| WIDDER KENNETH JDirector | Grant / award | +910 | $0.00 | $0 | Jun 6, 2026 | Form 4 ↗ |
| Wilkins Joseph D Jr.Director | Grant / award | +6,829 | $0.00 | $0 | May 29, 2026 | Form 4 ↗ |
| Chiminski John RDirector | Grant / award | +6,829 | $0.00 | $0 | May 29, 2026 | Form 4 ↗ |
| Michael Edward L.Director | Grant / award | +6,829 | $0.00 | $0 | May 29, 2026 | Form 4 ↗ |
| Dilsaver Evelyn SDirector | Grant / award | +6,829 | $0.00 | $0 | May 29, 2026 | Form 4 ↗ |
| Strobeck MatthewDirector | Grant / award | +6,829 | $0.00 | $0 | May 29, 2026 | Form 4 ↗ |
| Huennekens R ScottDirector | Grant / award | +6,829 | $0.00 | $0 | May 29, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding QDEL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 4.1M | $72.0M | 0.06% | Jun 30, 2026 |
| Fidelity Value Fund Fidelity Capital Trust | 3.8M | $63.8M | 0.61% | Jul 31, 2026 |
| Invesco Small Cap Value Fund AIM Sector Funds (Invesco Sector Funds) | 3.0M | $50.6M | 0.46% | Jul 31, 2026 |
| Avantis U.S. Small Cap Value ETF American Century ETF Trust | 3.3M | $47.1M | 0.15% | Aug 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.2M | $38.1M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.8M | $31.5M | 0.04% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.6M | $27.4M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Value Fund Fidelity Securities Fund | 1.7M | $20.8M | 0.41% | Apr 30, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 1.0M | $17.8M | 0.17% | Jun 30, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 990.7K | $17.4M | 0.03% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list QDEL's shares (CUSIP 219798105), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Newtyn TE Partners, LPSCHEDULE 13G/A · passive (13G) · 3.4M shares5.0%
Nov 16, 2026 · ↗ - Newtyn Management, LLCSCHEDULE 13G/A · passive (13G) · 5.3M shares7.8%
Nov 16, 2026 · ↗ - Stowers Institute for Medical ResearchSCHEDULE 13G · passive (13G) · 3.9M shares5.7%
Nov 16, 2026 · ↗ - American Century Companies, Inc.SCHEDULE 13G · passive (13G) · 3.9M shares5.7%
Nov 16, 2026 · ↗ - American Century Investment Management, Inc.SCHEDULE 13G · passive (13G) · 3.9M shares5.7%
Nov 16, 2026 · ↗ - American Century ETF TrustSCHEDULE 13G · passive (13G) · 3.8M shares5.5%
Nov 16, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 4.0M shares5.8%
Oct 7, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 4.0M shares5.8%
Oct 7, 2026 · ↗ - T. Rowe Price Investment Management, Inc.SCHEDULE 13G/A · passive (13G) · 1.7M shares2.6%
Aug 14, 2026 · ↗ - Newtyn TE Partners, LPSCHEDULE 13G/A · passive (13G) · 4.3M shares6.3%
Aug 14, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming QuidelOrtho Corp as client
No lobbying filings found naming QuidelOrtho Corp as the client.
Government Contracts
Federal awards to QuidelOrtho Corp · USAspending
No federal contract awards found for QuidelOrtho Corp.
U.S. Patents
Recent USPTO applications naming QuidelOrtho Corp
No USPTO patent applications found for QuidelOrtho Corp.
Annual Financials
From QDEL's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $2.73B | $2.78B | $3.00B | $3.27B | $1.70B |
| Operating income | -$919.2M | -$1.96B | $139.1M | $843.7M | $906.0M |
| Net income | -$1.13B | -$2.05B | -$10.1M | $548.7M | $704.2M |
| Diluted EPS | -$16.69 | -$30.54 | -$0.15 | $9.56 | $16.43 |
| Operating cash flow | $105.2M | $83.0M | $280.2M | $885.3M | $805.9M |
| Cash and equivalents | $169.8M | $98.3M | $118.9M | $292.9M | $802.8M |
| Total assets | $5.77B | $6.42B | $8.56B | $8.86B | $2.43B |
| Total liabilities | $3.85B | $3.44B | $3.56B | $3.92B | $501.0M |
| Shareholders' equity | $1.92B | $2.98B | $5.01B | $4.93B | $1.93B |
As QuidelOrtho Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in QDEL's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 5.02, 9.01Results of operations · Officer / director changeNov 3, 2026
EDGAR ↗ - 8-K · Items 1.01, 9.01Material agreementSep 23, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureJun 23, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 16, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 5, 2026
EDGAR ↗
About QuidelOrtho Corp
From SEC EDGAR company records
Industry (SIC 2835)In Vitro & In Vivo Diagnostic Substances
SectorHealthcare
HeadquartersSAN DIEGO, CA
SEC CIK0001906324 ↗
Former namesCoronado Topco, Inc.





